How many 8-K filings has Metagenomi, Inc. filed?

Metagenomi, Inc. (MGX) has 9 8-K (Current Event Report) filings on record, spanning Feb 2024 to Nov 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Metagenomi, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Metagenomi, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Metagenomi, Inc. (MGX) — 8-K Filings

All 8-K filings from Metagenomi, Inc.. Browse 9 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (9)

Metagenomi Files 8-K on Financials and Operations — Nov 12, 2025 Risk: low
Metagenomi, Inc. filed an 8-K on November 12, 2025, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Stat
Metagenomi Enters and Terminates Material Agreements — Oct 1, 2025 Risk: medium
On September 29, 2025, Metagenomi, Inc. entered into a material definitive agreement and also terminated a material definitive agreement. The company, formerly
Metagenomi Files 8-K on Shareholder Vote Matters — Jun 11, 2025 Risk: low
Metagenomi, Inc. filed an 8-K on June 11, 2025, reporting on matters submitted to a vote of security holders as of June 10, 2025. The filing indicates that the
Metagenomi Acquires Novel Therapeutics — May 14, 2025 Risk: medium
Metagenomi, Inc. announced on May 14, 2025, that it has entered into a definitive agreement to acquire all outstanding equity interests of Novel Therapeutics, I
Metagenomi Appoints New CSO, Adds Director — Jan 16, 2025 Risk: low
Metagenomi, Inc. announced on January 13, 2025, the appointment of Dr. Brian Atwood as Chief Scientific Officer and the election of Dr. Sarah E. Michaels to its
Metagenomi Files 8-K Report — Dec 10, 2024 Risk: low
On December 9, 2024, Metagenomi, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific materi
Metagenomi Files 8-K — Sep 3, 2024 Risk: low
Metagenomi, Inc. filed an 8-K on September 3, 2024, to report other events and financial statements. The filing does not contain specific details about the natu
Metagenomi Files 8-K: Agreement Termination & Financial Update — May 1, 2024 Risk: medium
Metagenomi, Inc. filed an 8-K on May 1, 2024, reporting on the termination of a material definitive agreement and its results of operations and financial condit
Metagenomi Amends Bylaws, Reports Fiscal Year Change — Feb 13, 2024 Risk: low
Metagenomi, Inc. filed an 8-K on February 13, 2024, reporting amendments to its Articles of Incorporation or Bylaws. The filing also indicated a change in its f

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX